Ganyen Sage a Dakunan Kicin da ke Kara Karfin Multitasking Lokacin Damuwa a Sa'a Daya
Ganyen sage (Salvia officinalis) na ɗaya daga cikin ƙananan ganyen da ake amfani da su wajen dafa abinci, amma a ƙarshe ya zama abin sha’awa ga masu bincike saboda yadda yake tasiri a kwakwalwa. A wani gwaji na dakin bincike da ba a san wanda ya karɓi magani ba (double‑blind), ƙwayar 600 mg ta ganyen sage busasshe ta inganta aikin multitasking a ƙarƙashin damuwa, tare da haɓaka faɗakarwa, natsuwa da jin daɗi. Abin mamaki, ƙwayar 300 mg ba ta haifar da wannan tasiri ba; a maimakon haka, ta rage damuwa amma ta rage ƙarfi yayin aikin.
Binciken ya fito ne daga Jami'ar Northumbria a Birtaniya, an wallafa shi a Neuropsychopharmacology shekara ta 2006, inda aka yi nazari kan sage a matsayin nootropic (ƙara tunani) ga mutanen da ke fuskantar damuwa da buƙatar mayar da hankali.
Me Ya Sa Sage? Hanyar Acetylcholine
Acetylcholine sinadarin saƙon ƙwayoyin ƙwaƙwalwa ne da ke da alaka kai tsaye da hankali, koyo da tunawa. Enzayim ɗin da ake kira cholinesterases sukan rushe shi. Idan an toshe waɗannan enzayim, acetylcholine zai riƙe a jiki tsawon lokaci – wannan ne asalin magungunan da ake amfani da su wajen rage alamun cutar Alzheimer.
Sage ya ja hankalin masana saboda gwaje‑gwajen in‑vitro sun nuna yana da ƙarfi wajen toshe cholinesterase, musamman acetylcholinesterase, fiye da butyrylcholinesterase. Wannan yana nuni da yiwuwar ƙara yawan acetylcholine a kwakwalwa, wanda a kaɗan ke haifar da ƙaruwar tunani da yanayin zuciya.
Lura: sakamakon in vitro ne, wato an yi a ƙasa da dakin gwaji ba a jikin mutane ba. Don haka ba mu da tabbacin yadda wannan zai shafi jiki kai tsaye.
Binciken Stress‑Battery
Masu binciken sun ƙirƙiri wani gwaji mai ƙalubale domin tantance tasirin sage a lokacin damuwa.
- Mahalarta: Matasa talatin masu lafiya
- Tsari: Double‑blind, placebo‑controlled, counterbalanced crossover – kowa ya gwada kowane magani
- Lokaci: Kwanaki uku na gwaje‑gwaje, kowanne tazarar mako ɗaya
- Magunguna: Placebo, 300 mg ganyen sage busasshe, ko 600 mg ganyen sage busasshe – kowanne a ƙwayar ɗaya
- Ma'aunin yanayi: Bond‑Lader da State‑Trait Anxiety Inventory (STAI), an auna kafin ba da ƙwaya da sa’o’i 1 da 4 bayan ba da shi
- Matsin lamba: Mintuna 20 na Defined Intensity Stress Simulator (DISS), wani shirin multitasking na kwamfuta da ke ba mahalarta ayyuka da dama a lokaci guda
An auna yanayin zuciya a matakai daban‑daban, don a gani yadda mutum ke ji a lokacin hutu da kuma bayan gwajin damuwa.
Sakamako Bisa Ga Kima
600 mg – Ingantaccen Tasiri
- Faɗakarwa, natsuwa da gamsuwa sun ƙaru kafin a fara DISS.
- Aikin DISS ya inganta a sa’o’i 1 da 4 bayan ba da ƙwaya.
- Tasirin ya ci gaba har zuwa awa huɗu bayan shan maganin.
300 mg – Tasiri Mai Rikitarwa
- An ga raguwa a damuwa a ma’aunin yanayi kafin a fara DISS, wanda alama ce mai kyau.
- Amma wannan natsuwa ta ɓace da zarar an kammala DISS, inda aka samu rashin faɗakarwa da raunin aiki a lokacin gwaji.
Saboda haka, ƙimar 300 mg ba ta haifar da fa’idar da aka samu daga 600 mg ba; a maimakon haka, ta iya jawo raguwar ƙarfi a lokutan da ake buƙatar hankali sosai.
Darasin 300 mg vs 600 mg
Binciken bai fayyace dalilin da ya sa ƙimomi biyu ke haifar da sakamako daban‑daban ba, kuma yin zato kan wannan abu ba gaskiya bane. Zai yiwu ƙimar ƙanana ba ta samar da isasshen tasirin faɗakarwa ba da zai tallafa wa aikin damuwar mai ƙalubale.
Mahimmanci: kima tana da tasiri. Idan ka karanta “sage na rage damuwa” kuma ka sha ƙimar 300 mg kafin wani aikin da ke buƙatar tunani sosai, ka shirya fuskantar sakamako daban da na 600 mg.
Ƙuntatawa Da Ya Kamata Ka Sani
- Kwaya ɗaya kawai. Binciken ya duba tasirin ɗaya‑ɗaya a lokacin gwaji; ba ya magana kan shan sage a kai‑kai na tsawon makonni.
- Samfurin karami. Mahalarta talatin ne, matasa masu lafiya. Sakamako na iya bambanta a manya, masu ciwon zuciya ko cututtukan kwakwalwa.
- Matsayin dakin gwaji. DISS na kwamfuta ba ya maye gurbin ainihin yanayin aiki na yau da kullum ko gajimareworin damuwa.
- Shekarar bincike. An yi shi a 2006; tun daga lokacin an gudanar da ƙarin bincike kan sage, amma wannan takarda ba ta ba da cikakkiyar fahimta ba.
- Hujja mai ƙaranci. Tasirin cholinesterase an nuna a in‑vitro ne, ba a tabbatar da alakar sa da sakamakon a jikin mutum ba.
Abubuwan Da Za Ka Iya Aiwatarwa
Idan kana tunanin gwada waɗannan ƙwayoyi, ga abubuwan da ya kamata ka sani (ba shawarwarin likita ba):
- Kima da aka gwada: 600 mg ganyen sage busasshe ya nuna fa’ida; 300 mg ba ta haifar da tasiri mai ma’ana ba.
- Lokaci: A gwajin, an auna bayan sa’o’i 1 da 4; don haka shan sage kusan awa ɗaya kafin aikin da ke buƙatar hankali zai iya zama mafi dacewa.
- Tsawon tasiri: Fa’idar 600 mg ta ci gaba har zuwa awa huɗu.
- Waɗanda za su amfana: Dalibai masu shirin jarrabawa, masu aikin da ke buƙatar tunani mai zurfi, ko waɗanda ke fuskantar damuwa a aiki.
- Nau’in samfur: An yi amfani da ganyen sage busasshe. Fure‑fure ko man kamshi ba su daidai ba kuma ba su da tasirin da aka gwada a wannan bincike.
Shawarwarin Tsaro
Sage ganye ne da ake amfani da shi a girke‑girke, amma “na halitta” ba yana nufin “ba zai iya cutarwa ba”.
- Thujone. Sage na ɗauke da thujone, wani sinadari da ke iya zama haɗari idan aka ci da yawa. Ka bi ƙimar da aka rubuta a kan lakabi kuma kada ka wuce adadin da aka ba da shawara.
- Man kamshi. Man kamshi na sage yana da ƙarfi sosai – kada a sha shi a manyan adadi.
- Mata masu ciki da shayarwa. An ba da shawarar mata masu ciki su guji shan sage a manyan ƙima; mata masu shayarwa da masu cutar kwakwalwa su tuntuɓi likita kafin amfani.
- Magunguna da yanayin lafiya. Idan kana shan magunguna – musamman na epilepsy, sukari, ko magungunan kwakwalwa – ka tuntuɓi likita ko ƙwararren mai ba da magani kafin ka gwada sage.
Kammalawa
Binciken ya nuna cewa ganyen sage na iya ƙara faɗakarwa, natsuwa da inganta aikin multitasking a lokacin damuwa, amma dole ne a yi amfani da shi a ƙima daidai. 600 mg ya nuna tasiri mai ƙarfi, yayin da 300 mg ya haifar da ragin faɗakarwa da ƙarfi a lokacin aikin. Saboda gwajin ya yi kan matasa talatin a dakin gwaji, ya kamata a ɗauki sage a matsayin wani abu da ke da ɗimbin damar bincike, ba a matsayin maganin ƙarshe ba.
